SILO Pharma Inc’s recently made public that its CEO and President Weisblum Eric acquired Company’s shares for reported $812.0 on Apr 05 ’24. In the deal valued at $2.03 per share,400 shares were bought. As a result of this transaction, Weisblum Eric now holds 175,432 shares worth roughly $0.31 million.
Then, Weisblum Eric bought 600 shares, generating $1,176 in total proceeds. Upon buying the shares at $1.96, the CEO and President now owns 175,032 shares.
Before that, Weisblum Eric bought 1,100 shares. SILO Pharma Inc shares valued at $2,101 were divested by the CEO and President at a price of $1.91 per share. As a result of the transaction, Weisblum Eric now holds 174,432 shares, worth roughly $0.31 million.
Price Performance Review of SILO
On Tuesday, SILO Pharma Inc [NASDAQ:SILO] saw its stock fall -10.55% to $1.78. Over the last five days, the stock has lost -8.25%. SILO Pharma Inc shares have risen nearly 23.61% since the year began. Nevertheless, the stocks have fallen -16.82% over the past one year. While a 52-week high of $3.05 was reached on 04/09/24, a 52-week low of $1.22 was recorded on 01/22/24. SMA at 50 days reached $1.7739, while 200 days put it at $1.7110. A total of 5.25 million shares were traded, compared to the trading of 59300.0 shares in the previous session.
Levels Of Support And Resistance For SILO Stock
The 24-hour chart illustrates a support level at 1.6167, which if violated will result in even more drops to 1.4533. On the upside, there is a resistance level at 2.0467. A further resistance level may holdings at 2.3133. The Relative Strength Index (RSI) on the 14-day chart is 42.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0630, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.18%. Stochastics %K at 26.17% indicates the stock is a holding.
